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Chronic disease — Research
illness. It is argued that patients are more than
the sum of their parts, and that, using a single-
morbidity model, we fail to grasp the pattern
of disease, leading to inadequate manage-
ment.4 Calls are growing for a more holistic






Objectives:  To estimate the prevalence and patterns of multimorbidity in a sample of 
patients attending general practice, in the population who attended general practice in 
2005, and in the Australian population.
Design, setting and participants:  Secondary analyses of data from a study of 
prevalence of selected conditions (a substudy of the BEACH [Bettering the Evaluation 
And Care of Health] program); data were provided by 305 general practitioners for 9156 
patients seen in July–November 2005, based on knowledge of the patient, patient self-
rt, and medical records. Listed conditions were classified according to the 
ulative Illness Rating Scale morbidity domains.
 outcome measures:  Prevalence of morbidity in each domain; prevalence of 
ific patterns of multimorbidity (defined as presence of morbidity in two or more 
ains).
Results:  Prevalence of multimorbidity was estimated as 37.1% of surveyed patients, 
29.0% of people who attended a GP in 2005, and 25.5% of the Australian population. 
Prevalence and complexity (number of domains present) increased with age: 83.2% of 
surveyed patients aged 75 years or older had multimorbidity, 58.2% had morbidity in three 
or more domains, and 33.4% in four or more. Prevalence of multimorbidity did not differ 
between the sexes. The most common morbidity combinations were arthritis/chronic back 
pain + vascular disease (15.0% of sample), a psychological problem + vascular disease 
(10.6%) and arthritis/chronic back pain + a psychological problem (10.6%). We estimate 
that 10.6% of people attending a GP in 2005 and 9.3% of the population have arthritis/
chronic back pain + vascular disease (± other morbidity types studied), and this group 
accounted for about 15.2 million Medicare-claimed general practice encounters in 2005.
Conclusions:  This study provides the first insight into prevalence and patterns of 
multimorbidity in Australia. Knowledge of the common combinations of multimorbidity 
may help in planning the health services needed in the future by an ageing population 
MJA 2008; 189: 72–77
with an increasing burden of multimorbidity.
See also page 66he
ma
disT  health care system in Australia, as inny other countries, focuses on singleeases. Payment structures increas-
ingly support single chronic diseases,1,2 and
guidelines for care usually take a single-
morbidity approach.3 This is a challenge for
primary care physicians, who care for the
“whole” patient, as the presence of multimor-
bidity has implications for managing chronic
Research into multiple morbidity first con-
centrated on measurement of comorbidity,
defined as “the existence or occurrence of any
distinct additional disease entity in a patient
who has the index disease under study”.8
More recent interest is in the mix of morbidi-
ties (multimorbidity) — the “co-occurrence of
two or more diseases within one person with-
out defining an index-disease”.7 Studies have
investigated the relationship of multimorbidity
(often with severity scores) with quality of
life,9-11 utilisation of medical services,12 hosp-
italisations and mortality.13 Some studies use
self-report surveys, and others use administra-
tive data12 or data from primary care records.14
However, the study of multimorbidity is
still in its infancy. A 2005 literature review
identified few articles on multimorbidity,
compared with the vast literature on specific
diseases.15 This is despite the fact that multi-
morbidity has an estimated prevalence of
60% among 65–74-year-olds, far higher than
the prevalence of each individual disease.15
As in any new field, there are problems in
measuring multimorbidity. In particular, the
number and types of disease selected and
their grouping greatly affect prevalence esti-
mates. An international literature review of
published data found widely varying meth-
ods and results. Although multimorbidity
was always defined as the presence of two or
more diseases, the morbidities included var-
ied widely, as did study populations, age
ranges and subgroups, and denominators for
prevalence estimates.16
There are currently no published Austral-
ian data on population prevalence of multi-
morbidity. There are a few reports on
comorbidities of selected target diseases
drawn from the National Health Survey17
but, as discussed elsewhere,18 this is based on
patient self-report, which is of questionable
reliability.
A Western Australian study in the early
1990s used hospital chart review to describe
“comorbidity”, using the Charlson Comor-
bidity Index. For a subsample of patients, the
patient’s general practitioner at the time of
admission was also asked to report (by tick
box) the diseases present at that time. The
authors rejected the GP survey as unreliable
because GPs reported only 58% of morbidi-
ties found in hospital charts, but 20% more
morbidities not matched in hospital charts.19
It is curious that the additional GP diagnoses
were judged erroneous. The project was geo-
graphically limited, involved a small selected
sample, and must have relied on retrospective
review of GP records.
In this study, we take a first step in the
prospective measurement of the prevalence
of multimorbidity in the population attend-
ing general practice in Australia and extra-
polate these results to provide estimates for
the Australian population.
METHODS
The data collection methods have been
described elsewhere.18 In summary, this is a
secondary analysis of data from a substudy
of the BEACH (Bettering the Evaluation And
Care of Health) program, a continuous
national study of general practice activ-
ity.20,21 The substudy investigated preva-
lence of selected conditions among 9156
patients attending 305 GPs in July–Novem-
ber 2005. GPs were asked which of a list of
morbidities were currently being managed
for each patient, using their knowledge of
the patient, the patient’s self-report, and the
medical record.MJA • Volume 189 Number 2 • 21 July 2008
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GPs, each providing data about a cluster of
encounters. SAS version 9.1.3 (SAS Institute
Inc, Cary, NC, USA) was used to adjust for
clustering at individual GP level. The sample
survey results were adjusted to provide prev-
alence estimates for the population attending
a GP in 2005–2006, and the population of
Australia, as described elsewhere.18
Three methods have been validated to
some degree for measuring multimorbidity:
the Johns Hopkins Adjusted Clinical Group
case-mix system,12 the Charlson Comorbidity
Index,22 and the Cumulative Illness Rating
Scale (CIRS).10,23,24 We chose the last as it has
been validated25 and applied in family prac-
tice.9,10,16,24 It uses the presence of illness in
each of 14 organ domains plus a measure of
severity of each domain to provide an index of
total chronic medical illness burden. We allo-
cated the surveyed morbidities into these syn-
ergistic domains (ie, management of one
problem is usually beneficial for management
of another within the group). They fell into
eight of the 14 domains. Our category “malig-
nant neoplasms” was too broad to be allocated
to a single CIRS domain, so we added it as an
independent morbidity type, giving a total of
nine morbidity domains (Box 1).
Respondents with more than one sur-
veyed morbidity within a single CIRS
domain were counted only once for that
domain. Prevalence of illness in each CIRS
morbidity domain among the sample was
calculated. Multimorbidity was defined as
presence of illness in two or more morbidity
domains. Results are presented as estimated
prevalence of each domain and of combina-
tions of domains in the sample; estimated
prevalence among patients who attended a
primary care practitioner at least once in
2005–2006, after adjustment for attend-
ance rates by age–sex category; and esti-
mated population prevalence.18 Estimated
numbers of national encounters with
patients having each multimorbidity combi-
nation were made through simple extra-
polation from the crude prevalence estimate
to the number of services by GPs in April
2005 – March 2006.26
The most common combinations of
domains were first investigated for all
patients with at least two morbidity
domains, followed by patterns among those
with three or more (a subgroup of the first
analytical group), and then patterns among
those with four or more (a subgroup of both
previous groups). Only the 12 most com-
mon combinations of two or more morbid-
ity types are presented here. The full results
for all combinations are available at the




Ethics committees of the University of Syd-
ney and the Australian Institute of Health
and Welfare approved the BEACH study
and the substudy on which this analysis is
based.
RESULTS
Prevalence of each morbidity domain
Among the 9156 patients surveyed, vascular
problems were the most prevalent morbidity
domain (31.5%), followed by arthritis/chronic
back pain (26.5%), and psychological prob-
lems (24.7%) (Box 2). The interpretation of
these results is that, for example, 31.5% of GP
encounters are with patients who have at least
one of the listed vascular conditions.
Because older people have more chronic
diseases and attend GPs more often, adjust-
ment of results to the total population
attending general practice resulted in a
decrease in estimated prevalence of all mor-
bidity domains. For example, we estimate
that 24.6% of patients who attended a GP
once in 2005–2006 have a vascular disease
currently being managed (Box 2).
Prevalence of multimorbidity
Of the 9156 patients, 39.6% had no illness
in any of the morbidity domains, and 23.3%
had illness in only one domain. The remain-
ing 3398 (37.1%) were classed as having
multimorbidity. Almost two-thirds (61.5%)
of patients with illness in at least one of the
morbidity domains had multimorbidity, by
far the most having illness in two or three
domains. However, 10.1% of the sample
had illness in four or more domains, and
1.8% in six or more. Adjusted results sug-
gested that 29.0% of the population who
attend general practice, and 25.5% of the
population overall, have multimorbidity as
measured in this study (Box 3).
There was no difference in prevalence of
multimorbidity between male and female
patients (Box 4). Prevalence increased stead-
ily with age, from 2.6% among the sampled
people younger than 25 years to almost half
of those aged 45–64 years, three-quarters of
those aged 65–74 years, and four out of five
of those aged 75 years or older (Box 4).
Likelihood of increased numbers of morbid-
ity domains also steadily increased with age,
with 0.6% of patients younger than 25 years
having three or more morbidity domains,
compared with 58.2% of those aged 75
years or older having three or more, and
33.4% having four or more domains.
After adjustment, 19.3% of patients who
attend general practice had multimorbidity
involving vascular disease, 16.6% involving
arthritis and/or chronic back pain, and
14.8% involving a psychological problem
(Box 2). The patients most likely to have
multimorbidity were those with cardiac dis-
ease (ratio of adjusted prevalence of multi-
morbidity to morbidity, 98.6% [7.0%/
7.1%]) and those with cerebrovascular dis-
ease (91.7%). Those least likely had asthma/
chronic obstructive airways disease (59.8%)
or a psychological problem (67.0%).
Common multimorbidity combinations
Box 5 shows the 12 most common combina-
tions of two morbidity domains for all
patients with multimorbidity.
The most prevalent morbidity combina-
tion was arthritis/chronic back pain + vas-
cular disease (15.0% of the sample),
followed by psychological problem + vas-
cular disease and arthritis/back pain + psy-
chological problem (both 10.6%) (Box 5).
The most common combinations among
those with morbidity in three or more
domains were arthritis/back pain + vascular
disease + psychological problem (6.1%)
and arthritis/back pain + vascular disease +
1  Classification of surveyed 
morbidities into Cumulative Illness 




Cardiac Ischaemic heart disease, 
chronic heart failure





Psychological Depression, anxiety, 
insomnia, other 
psychological problem




Arthritis (all types), 
chronic back pain








* Malignant neoplasms are not a discrete CIRS 
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(5.3%). The most common combinations
among those with morbidity in four or
more domains were arthritis/back pain +
vascular disease + GORD + psychological
problem (2.6%) and arthritis/back pain +
vascular disease + GORD + cardiac prob-
lem (2.2%) (Appendix, Multimorbidity,
http ://www.fmrc.org.au/publications/
appendices/).
In Box 5, Column 4 shows the estimated
number of Medicare-claimed encounters
nationally in 2005–2006 with patients who
have each multimorbidity combination
(although some have additional morbidity
domains). The adjusted estimate of the pro-
portion of people attending a GP at least
once in the study year who have each
combination of diseases (± other morbidity
domains) is provided in Column 5, and the
adjusted estimate for the total population in
Column 6. For example, 10.6% of the
patients attending GPs in 2005–2006, and
9.3% of the community as a whole (about
1.8 million people) have arthritis/chronic
back pain + vascular disease (± other mor-
bidity domains), and this group of people
accounted for an estimated 15.2 million
general practice Medicare-claimed encoun-
ters in 2005–2006.
Columns 7 and 8 indicate the likelihood
of more complex morbidity among people
in the population with the listed combina-
tions. For example, of the estimated 9.3% of
the population who have arthritis/chronic
back pain + vascular disease, 31.2% have
morbidity in one other studied domain, and
48.2% have morbidity in two or more other
domains. Disease complexity was greatest
for those with arthritis/chronic back pain +
cardiac disease, 21.6% of whom had mor-
bidity in one other domain, and 72.2% in
two or more other domains. (More detailed
results for specific combinations are avail-
able in Appendix, Multimorbidity, http://
www.fmrc.org.au/publications/appendices/.)
DISCUSSION
This study has given a first insight into the
prevalence of multimorbidity in Australia. It
suggests that about three in 10 people who
2 Prevalence of morbidity in each CIRS domain and multimorbidity arising from that domain
Morbidity 
domain‡ No.
Prevalence in sample* (95% CI) (n = 9156) Prevalence in GP patient population† (95% CI) (n = 17 468 583)
Morbidity 
Multimorbidity arising in each domain 
Morbidity 
Multimorbidity arising in each domain 























































































































































CIRS = Cumulative Illness Rating Scale. GP = general practice. Psych = psychological problem. COAD = chronic obstructive airways disease. 
GORD = gastro-oesophageal reflux disease. CVD = cerebrovascular disease.
* Equates to estimated prevalence among patients in GP waiting room. † Estimated prevalence among patients who visited a GP at least once in a year. 
‡ Where domain included one or two surveyed morbidities, the morbidities are specified. § Arthritis/chronic back pain. ◆




Crude per cent of 
sample* (95% CI)
(n = 9156)
Estimated prevalence (95% CI)
GP patient population† Australian population‡
0 3624 39.6% (37.6%–41.6%) 46.9% (44.9%–48.9%) 53.2% 
1 2134 23.3% (22.3%–24.4%) 24.2% (23.0%–25.3%) 21.3% (20.3%–22.2%)
Multimorbidity 3398 37.1% 29.0% 25.5%
2 1499 16.4% (15.4%–17.3%) 14.0% (13.1%–14.9%) 12.3% (11.5%–13.1%)
3 971 10.6% (9.7%–11.5%) 8.0% (7.2%–8.7%) 7.0% (6.4%–7.7%)
4 513 5.6% (5.0%–6.2%) 4.0% (3.5%–4.4%) 3.5% (3.1%–3.9%)
5 254 2.8% (2.3%–3.2%) 1.9% (1.6%–2.2%) 1.7% (1.4%–2.0%)
6 113 1.2% (0.9%–1.5%) 0.8% (0.6%–1.0%) 0.7% (0.5%–0.9%)
7 41 0.4% (0.3%–0.6%) 0.3% (0.2%–0.4%) 0.3% (0.1%–0.4%)
8 7 0.1% (0–0.1%) 0.0% (0–0.1%) 0.0% (0–0.1%)
9 0 0 0 0
GP = general practice. * Equates to estimated prevalence among patients in GP waiting room. † Estimated 
prevalence among patients who visited a GP at least once in 2005–2006. ‡ Estimated prevalence among the 
Australian population. ◆74 MJA • Volume 189 Number 2 • 21 July 2008
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tralians overall, have multimorbidity as
defined in this study. This aligns with over-
seas estimates of 30% in Quebec, Canada,
and the Netherlands.14 Extrapolation sug-
gests that over 5 million Australians are cur-
rently being managed for diagnosed diseases
from at least two of the morbidity domains.
Our finding that prevalence and complex-
ity do not differ by sex but are highly age-
related are consistent with the results of
other studies.14 However, our prevalence
estimates for older patients (75% for 65–74-
year-olds and 83% for those aged 75 years
or over) are higher than those from Quebec
in 1999 (63.4%),15 the Netherlands in 1990
(> 60%) and the United States in 1999
(ranging from 54% among 65–70-year-olds
to 73% in those aged 80 years or more).16
All studies used different methods to meas-
ure multimorbidity, raising further questions
rather than providing answers.
Our study has the limitations reported else-
where in the adjustment processes used to
account for higher chance of selection associ-
ated with higher morbidity independent of
age and sex of patient.18 In addition, it
includes only diagnosed morbidities currently
under management and cannot consider mor-
bidities not yet diagnosed. Further, it includes
a limited number of morbidities, selected
because they are National Health Priorities or
because of their high frequency of manage-
ment in general practice.18 However, together
these morbidities account for about 80% of all
occasions of chronic disease27 management in
general practice in Australia (unpublished
BEACH data), and this is the only approach
possible given the cross-sectional patient sam-
pling processes. Surveyed patients with none
of the listed morbidities may have other,
unlisted, chronic diseases, and patients who
had one of the morbidity domains plus other
chronic diseases not studied would be classed
as not having multimorbidity. We therefore
cannot conclude that 29% of the population
has multimorbidity, but we can conclude that
this proportion has multimorbidity as defined
in this study.
Obesity was not included in the study, as it
did not fulfil the inclusion criteria at the time.
However, in 2005–2006, 22% of patients
attending a GP were classified as obese
(through self-reported height and weight),28
about the same prevalence as, for example,
arthritis (22.8%).18 As obesity has now been
added to the National Health Priorities, it
should be included in future studies. Other
morbidities that could be considered for
inclusion are renal impairment, osteoporosis
and other musculoskeletal conditions, and
their inclusion would certainly raise preva-
lence estimates for multimorbidity. We
believe the next study should be structured
on the basis of the CIRS domains and include
tick boxes for each of the more commonly
managed morbidities in general practice, as
well as other individual morbidities within
each domain relevant to government health
policy. Ideally, severity should be assessed
with multimorbidity, but would require a
separate study as this would be too demand-
ing for BEACH participants in the confines of
the GP–patient encounter.
Underlying these limitations is the lack of
an internationally accepted standard for meas-
uring multimorbidity. A clear conceptual
framework must be developed that includes a
consistent approach to measurement of multi-
morbidity and age categorisation in the study
population to allow comparison between
studies and populations.29
Some suggest that, if we are to deal with
an increasing prevalence of multimorbidity
in an ageing population, we need to know
about disease combinations so we can
design best practice guidelines for clini-
cians.5 They also note that continuing to
combine care plans will increase polyphar-
macy and the chance of adverse drug
events.5 Some multimorbidity combina-
tions are particularly problematic for both
patient and clinician. For example, combi-
nations of cardiac and respiratory system
morbidity have a particularly strong syner-
gistic negative effect.10 The common com-
bination of musculoskeletal morbidity with
vascular and upper gastrointestinal prob-
lems may result in a non-steroidal anti-
inflammatory agent increasing the mortal-
ity of the other two morbidities, particu-
larly in older patients.30 These issues are
often not considered in guidelines for indi-
vidual conditions.
Governments are currently considering
the structure and function of the Australian
health care system. Our study, although only
a first step in measuring prevalence of multi-
morbidity, may help inform planning of
health services of the future.
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4 Prevalence of levels of mulitmorbidity, by patient characteristics 
Patient 
characteristic No. in sample*
Prevalence of CIRS morbidity domains among the sample (95% CI)†
1 or more 2 or more 3 or more 4 or more
Sex‡
Male 3581 60.3% (57.7%–62.9%) 36.4% (33.7%–39.1%) 20.1% (17.8%–22.3%) 10.1% (8.5%–11.6%)
Female 5522 60.5% (58.4%–62.6%) 37.5% (35.2%–39.9%) 21.1% (19.3%–22.9%) 10.1% (8.9%–11.4%)
Age (years)‡
< 25 2047 20.2% (18.1%–22.3%) 2.6% (1.9%–3.4%) 0.6% (0.3%–0.9%) 0.2% (0–0.4%)
25–44 2281 43.9% (41.3%–46.5%) 14.7% (12.8%–16.6%) 3.9% (2.9%–4.8%) 1.1% (0.6%–1.6%)
45–64 2450 76.9% (74.7%–79.1%) 46.5% (43.6%–49.5%) 22.7% (20.4%–24.9%) 9.1% (7.6%–10.6%)
65–74 990 92.3% (90.5%–94.2%) 74.6% (71.3%–78.0%) 46.0% (42.2%–49.8%) 22.6% (19.5%–25.7%)
75 + 1343 96.2% (95.1%–97.3%) 83.2% (80.9%–85.6%) 58.2% (54.5%–61.9%) 33.4% (29.9%–36.8%)
CIRS = Cumulative Illness Rating Scale. * Denominator for prevalence. † Estimated prevalence among patients in general practice waiting room. ‡ Data were missing for 
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CIRS = Cumulative Illness Rating Scale. pa = per annum. GP = general practice. Psych = psychological problem. GORD = gastro-oesophageal reflux disease. 
COAD = chronic obstructive airways disease.
* Estimated prevalence among patients in GP waiting room. † Estimated prevalence among patients who visited a GP at least once in a year. 
‡ Estimated prevalence among the Australian population of 19 855 290 (2006 census). ◆76 MJA • Volume 189 Number 2 • 21 July 2008
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